Quintix Corporation Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Quintix Corporation's estimated annual revenue is currently $775k per year.(i)
  • Quintix Corporation's estimated revenue per employee is $155,000

Employee Data

  • Quintix Corporation has 5 Employees.(i)
  • Quintix Corporation grew their employee count by 0% last year.

Quintix Corporation's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Quintix Corporation?

Quintix Corporation is a leading global software development and services company, combining proven expertise in technology, and an understanding of emerging business trends. Quintix delivers a range of healthcare software products and solutions including a super-natural EHR application suite, On Demand dispatching portals for medical facilties and physicians, telehealth solutions, PACS and more. Quintix partners with OEM manufacturers to develop screws for a wide variety of orthopedic and spine applications & Surgical implant products. We also provide bioinformatics services. At Quintix, we possess the unique skills in combining knowledge and techniques with information technology and biotech settings. Our service platform and the usage of various bio software packages for interpretation and visualization of data in molecular biology includes Bioinformatics and Advanced data analysis, Development and maintenance of comprehensive range of molecular databases and more.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M50%N/A
#2
$0.4M50%N/A
#3
$0.4M50%N/A
#4
$0.6M50%N/A
#5
$0.4M5-17%N/A